Skip to content
Home
Medical Need
Our Science
Our Team
News
Home
Medical Need
Our Science
Our Team
News
CONTACT US
Vaderis Expanded Access Policy >
Home
Medical Need
Our Science
Our Team
News
Contact Us
Expanded Access Policy
Home
Medical Need
Our Science
Our Team
News
Contact Us
Expanded Access Policy
News
Vaderis News |
12/02/2025
Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results
READ MORE
Vaderis News |
11/17/2024
Vaderis Receives FDA Fast Track Designation for VAD044 for the Treatment of Hereditary Hemorrhagic Telangiectasia
READ MORE
Vaderis News |
11/05/2024
Vaderis Announces Acceptance of Abstract on VAD044 Proof-of-Concept Clinical Trial
READ MORE
Vaderis News |
08/27/2024
Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT
READ MORE
Vaderis News |
08/22/2022
Vaderis Therapeutics AG announces Clinical Proof-of-Concept Trial in HHT
READ MORE
